The Pink Sheet

“The Pink Sheet” provides in-depth coverage of the prescription pharmaceutical industry. Known as "The Bible" to the prescription pharmaceutical industry, this publication covers regulatory activities of the FDA, FTC and CMS; Congress; industry news, such as mergers and acquisition, new product introductions, and executive changes; and financial news, such as companies' sales/earning performance and stock activity. Its comprehensive coverage is vital for successful business development and commercialization strategies that drive profits. [1]